| Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups  the nitrogen atom not being part of nitro or nitroso groups (15,621) | 
|---|
| 10/08/2002 | US6462179 Conjugation to peptides, proteins, hormones, polysaccharides, nucleic acids, haptens, drugs, ligands, toxins, halophors, and other macromolecules  | 
| 10/08/2002 | US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases  | 
| 10/08/2002 | US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors  | 
| 10/08/2002 | US6462059 Treatment of disorders associated with smooth muscle contraction; urinary incontinence, asthma, premature labor, irritable bowel syndrome, congestive heart failure, angina, and cerebral vascular disease  | 
| 10/03/2002 | WO2002076995A2 2-amino-propanol derivatives  | 
| 10/03/2002 | WO2002076978A1 Δ1 pyrrolines  | 
| 10/03/2002 | WO2002076939A2 Cysteine protease inhibitors  | 
| 10/03/2002 | WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity  | 
| 10/03/2002 | WO2002076928A2 Alkylamine derivatives as antifouling agents  | 
| 10/03/2002 | WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists  | 
| 10/03/2002 | WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses  | 
| 10/03/2002 | WO2002076402A2 Fatty amine drug conjugates  | 
| 10/03/2002 | WO2001020331A9 Substrates and screening methods for transport proteins  | 
| 10/03/2002 | US20020143207 Process for the deprotection of protected thiols  | 
| 10/03/2002 | US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits  | 
| 10/03/2002 | US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine  | 
| 10/03/2002 | CA2442178A1 2-amino-propanol derivatives  | 
| 10/03/2002 | CA2441334A1 .delta.1 pyrrolines  | 
| 10/03/2002 | CA2441197A1 Alkylamine derivatives as antifouling agents  | 
| 10/03/2002 | CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses  | 
| 10/03/2002 | CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists  | 
| 10/02/2002 | EP1245558A1 Alkylamine derivates as anti-fouling agents  | 
| 10/02/2002 | EP1245550A1 Novel selective deacetylating agents  | 
| 10/02/2002 | EP1244624A1 Anthracene derivatives as anti-cancer agents  | 
| 10/02/2002 | EP1244614A2 Tryptase inhibitors  | 
| 10/02/2002 | EP1244610A1 Improved preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines  | 
| 10/02/2002 | EP0915832B1 Boronic compound complexing reagents and highly stable complexes  | 
| 10/01/2002 | US6458953 Valency platform molecules comprising carbamate linkages  | 
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity  | 
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes  | 
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity  | 
| 10/01/2002 | US6458781 Blockers calcium channel antagonists for strokes, brain disorders  | 
| 10/01/2002 | US6458381 Lipids and their use, for example, in liposomes  | 
| 09/26/2002 | WO2002074733A2 Tryptase-inhibitors  | 
| 09/26/2002 | WO2002034698A3 Phosgene-free process for preparing carbamates  | 
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness  | 
| 09/26/2002 | US20020137963 Process for preparing aryl-iminomethyl-carbamino acid esters  | 
| 09/26/2002 | US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example  | 
| 09/26/2002 | US20020137687 Novel compounds that inhibit tryptase activity  | 
| 09/26/2002 | DE10113965A1 New tetrazolylphenyl-substituted 1-pyrroline derivatives useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents  | 
| 09/26/2002 | CA2440482A1 Tryptase-inhibitors  | 
| 09/25/2002 | EP1243576A1 Processes for producing (aminomethyl)trifluorocarbinol derivatives  | 
| 09/25/2002 | EP1242368A2 Process for the synthesis of polycarbamates  | 
| 09/25/2002 | EP0907635B1 Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol  | 
| 09/25/2002 | EP0835257B1 Intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds  | 
| 09/25/2002 | CN1371360A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof  | 
| 09/25/2002 | CN1371359A Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha  | 
| 09/24/2002 | US6455587 Aromatic sulfonyl derivatives  | 
| 09/24/2002 | US6455585 Have a higher analgesic activity, a lower toxicity and a longer effective time period than tramadol.  | 
| 09/24/2002 | US6455550 N-alkanoylphenylalanine derivatives  | 
| 09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity  | 
| 09/24/2002 | US6455515 Salicylohydrazide derivatives, processes and intermediates for their preparation, compositions comprising them, and their use  | 
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors  | 
| 09/24/2002 | CA2096223C Treatment for tissue ulceration  | 
| 09/19/2002 | WO2002072559A1 Process to intermediates for biologically active compounds  | 
| 09/19/2002 | WO2002036548A3 Method for stereoselectively producing hydrazino cycloalkenes and diamino cycloalkanes  | 
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof  | 
| 09/19/2002 | US20020133040 Carbamate solutions  | 
| 09/19/2002 | US20020133020 Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates  | 
| 09/19/2002 | US20020132849 2-Amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors  | 
| 09/19/2002 | US20020132766 Design, preparation, and properties of antibacterial beta-peptides  | 
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use  | 
| 09/18/2002 | EP1241528A2 Radical polymerizable compounds for image forming materials  | 
| 09/18/2002 | EP1241159A1 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof  | 
| 09/18/2002 | EP1239843A1 New (aminopropyl)methylphosphinic acids  | 
| 09/18/2002 | EP0929516B1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect  | 
| 09/18/2002 | EP0888322B1 Electrophilic ketones for the treatment of herpesvirus infections  | 
| 09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors  | 
| 09/17/2002 | US6452038 Fluoroalkyloxy dispersant  | 
| 09/17/2002 | US6451973 Human immunodeficiency virus (hiv) protease inhibitors  | 
| 09/17/2002 | US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity  | 
| 09/17/2002 | US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity  | 
| 09/17/2002 | US6451740 Uracil compounds and use thereof  | 
| 09/17/2002 | CA2122036C Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form  | 
| 09/12/2002 | WO2002070653A2 Peptide deformylase inhibitors  | 
| 09/12/2002 | WO2002070500A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists  | 
| 09/12/2002 | WO2002070493A1 Bisaryl derivatives having fsh receptor modulatory activity  | 
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents  | 
| 09/12/2002 | US20020128510 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines  | 
| 09/12/2002 | US20020128269 Piperazine derivatives  | 
| 09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques  | 
| 09/12/2002 | US20020127202 Compounds and compositions for delivering active agents  | 
| 09/12/2002 | CA2438737A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists  | 
| 09/12/2002 | CA2434184A1 Bisaryl derivatives having fsh receptor modulatory activity  | 
| 09/11/2002 | EP1238031A1 Curable coating compositions containing carbamate functional reactive additives  | 
| 09/11/2002 | EP1237857A1 New phenalkyloxy-phenyl derivatives  | 
| 09/11/2002 | EP1237856A1 New tri-substituted phenyl derivatives and analogues  | 
| 09/11/2002 | EP1237852A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect  | 
| 09/11/2002 | EP1237847A1 Method for the stereoselective synthesis of cyclic amino acids  | 
| 09/11/2002 | EP1237548A1 Il-8 receptor antagonists  | 
| 09/11/2002 | EP0912504B1 Oxazolidine ester  | 
| 09/11/2002 | CN1368956A Carbamate derivatives and agricultural/horticultural bactericides  | 
| 09/11/2002 | CN1090612C Amine derivatives of oxo-and hydroxy-substituted hydrocarbons  | 
| 09/10/2002 | US6448414 Hydrolytic kinetic resolution of cyclic substrates  | 
| 09/10/2002 | US6448402 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol  | 
| 09/10/2002 | US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein  | 
| 09/10/2002 | US6448269 Such as 6-(n-(4-(aminoiminomethyl)benzoyl)amino)-3,4-dihydro-4,4-dimethyl-2h-1 -benzopyran-2-yl)acetic acid; inhibiting platelet aggregation or fibrinogen binding or preventing thrombosis  | 
| 09/10/2002 | US6448228 Functionalized oligopeptide having high fungicidal activity; one or two aliphatic amino acids such as valine, leucine and isoleucine, conjugated to one or two aromatic amino acids, such as phenyl-glycine, phenylalanine and beta-phenylalanine  | 
| 09/06/2002 | WO2002068592A2 Non-racemic hexafluoreleucine, and methods of making and using it  | 
| 09/06/2002 | WO2002068428A1 Method of preparing cephalosporins using 4-hydroxyphenylglycine derivatives  |